DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Häring HU, Merker L, Seewaldt-Becker E. et al.
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.
Diabetes Care 2014;
37: 1650-1659
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.